Drug safety tests and subsequent clinical experience.
作者信息
Fletcher A P
出版信息
J R Soc Med. 1978 Sep;71(9):693-6. doi: 10.1177/014107687807100915.
Abstract
摘要
相似文献
1
Drug safety tests and subsequent clinical experience.药物安全性测试及后续临床经验。
J R Soc Med. 1978 Sep;71(9):693-6. doi: 10.1177/014107687807100915.
2
Industrial research in the quest for new medicines.探寻新药的工业研究。
Clin Exp Pharmacol Physiol. 1974 May-Jun;1(3):183-95. doi: 10.1111/j.1440-1681.1974.tb00541.x.
3
Present status of clinical pharmacology and of regulatory requirements for preclinical and clinical evaluation of new drugs in Japan.
Clin Pharmacol Ther. 1974 Sep;16(3):577-84. doi: 10.1002/cpt1974163part2577.
4
Assessment of drug metabolites.药物代谢物的评估。
Drug Metab Pharmacokinet. 2011;26(2):121-2. doi: 10.2133/dmpk.dmpk-11-pf-902.
5
Clinical pharmacological evaluation in drug control.药品管制中的临床药理学评价。
Eur J Clin Pharmacol. 1973 Jun;6(1):69-73. doi: 10.1007/BF00561805.
6
Toxicology in the drug discovery and development process.药物发现与开发过程中的毒理学
Curr Protoc Pharmacol. 2006 Apr;Chapter 10:Unit10.3. doi: 10.1002/0471141755.ph1003s32.
7
Nonclinical Safety and Toxicology.非临床安全性与毒理学
Handb Exp Pharmacol. 2016;232:261-83. doi: 10.1007/164_2015_16.
8
Species selection considerations for preclinical toxicology studies for biotherapeutics.生物治疗药物临床前毒理学研究的物种选择考量
Expert Opin Drug Metab Toxicol. 2008 Jul;4(7):871-7. doi: 10.1517/17425255.4.7.871.
9
Compact Magnetic Resonance Imaging Systems-Novel Cost-Effective Tools for Preclinical Drug Safety and Efficacy Evaluation.紧凑型磁共振成像系统——用于临床前药物安全性和疗效评估的新型具有成本效益的工具。
Toxicol Sci. 2017 May 1;157(1):3-7. doi: 10.1093/toxsci/kfx024.
10
Exploratory toxicology as an integrated part of drug discovery. Part I: Why and how.探索性毒理学作为药物发现的一个组成部分。第一部分：原因和方法。
Drug Discov Today. 2014 Aug;19(8):1131-6. doi: 10.1016/j.drudis.2013.12.008. Epub 2013 Dec 22.
引用本文的文献
1
Toxicity Testing Using Organoids Made from Human-Induced Pluripotent Stem Cells Engineered to Report Oxidative Stress.使用经工程改造以报告氧化应激的人诱导多能干细胞制成的类器官进行毒性测试。
Methods Mol Biol. 2025;2924:131-143. doi: 10.1007/978-1-0716-4530-7_10.
2
Human iPSC-derived renal organoids engineered to report oxidative stress can predict drug-induced toxicity.经过工程改造以报告氧化应激的人诱导多能干细胞衍生的肾类器官能够预测药物诱导的毒性。
iScience. 2022 Feb 7;25(3):103884. doi: 10.1016/j.isci.2022.103884. eCollection 2022 Mar 18.
3
The flaws and human harms of animal experimentation.动物实验的缺陷与对人类的危害。
Camb Q Healthc Ethics. 2015 Oct;24(4):407-19. doi: 10.1017/S0963180115000079.
4
Self-organized Kidney Rudiments: Prospects for Better in vitro Nephrotoxicity Assays.自组织肾原基：改进体外肾毒性检测的前景
Biomark Insights. 2015 Jul 16;10(Suppl 1):117-23. doi: 10.4137/BMI.S20056. eCollection 2015.
5
A review of the Institute of Medicine's analysis of using chimpanzees in biomedical research.医学研究所关于在生物医学研究中使用黑猩猩的分析综述。
Sci Eng Ethics. 2014 Jun;20(2):481-504. doi: 10.1007/s11948-013-9442-7. Epub 2013 Apr 25.
6
Animal models and conserved processes.动物模型与保守过程。
Theor Biol Med Model. 2012 Sep 10;9:40. doi: 10.1186/1742-4682-9-40.
7
The Nuremberg Code subverts human health and safety by requiring animal modeling.纽伦堡法典通过要求动物模型来破坏人类健康和安全。
BMC Med Ethics. 2012 Jul 8;13:16. doi: 10.1186/1472-6939-13-16.
8
Human tissue in the evaluation of safety and efficacy of new medicines: a viable alternative to animal models?人体组织在新药安全性和有效性评估中的应用：动物模型的可行替代方案？
ISRN Pharm. 2011;2011:806789. doi: 10.5402/2011/806789. Epub 2011 Jul 6.
9
Is the use of sentient animals in basic research justifiable?在基础研究中使用有感知能力的动物是否合理？
Philos Ethics Humanit Med. 2010 Sep 8;5:14. doi: 10.1186/1747-5341-5-14.
Zotero 插件